Australia Medical Cannabis Market By Source (Hemp and Marijuana), By Derivative (CBD, THC and Others), By Application (Chronic Pain, Cancer, Anxiety and Depression, Arthritis, Epilepsy and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035
- Published date: March 2026
- Report ID: 180283
- Number of Pages: 288
- Format:
-
keyboard_arrow_up
-
-
- Cann Group (Refinanced and debt-restructured in 2025)
- Zelira Therapeutics
- AusCann Group Holdings Ltd
- Bod Science
- Althea Group
- Little Green Pharma (Announced merger with Cannatrek in Jan 2026)
- Incannex Healthcare
- Vitura Health Limited (Formerly Cronos Australia)
- Bioxyne
- Green Farmers
- ECS Botanics
- Tasmanian Botanics
Our Clients
- 180283
- March 2026
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
